Catalent
CTLT
#1594
Rank
C$15.01 B
Marketcap
$82.69
Share price
-0.35%
Change (1 day)
81.05%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : C$13.54 Billion

According to Catalent's latest financial reports the company's total assets are C$13.54 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30C$14.27 B5.48%
2022-06-30C$13.53 B19.85%
2021-06-30C$11.29 B6.35%
2020-06-30C$10.62 B30.85%
2019-06-30C$8.11 B36.23%
2018-06-30C$5.95 B32.76%
2017-06-30C$4.48 B12.25%
2016-06-30C$3.99 B2.64%
2015-06-30C$3.89 B18.19%
2014-06-30C$3.29 B6.22%
2013-06-30C$3.10 B-2.92%
2012-06-30C$3.19 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$1.87 B-86.17%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.52 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.10 B 26.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$0.54 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA